• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
REPL

REPL

Replimune Group, Inc.

NASDAQHealthcareBiotechnologyUS

USD9.98

+1.11 (+12.51%)

Rating:C

Company Profile

CEO

Sushil Patel

IPO Date

2018-07-20

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$8.80

Prev. Close

$8.87

Day Low

$8.80

Day High

$10.41

52W Low

$1.50

52W High

$13.24

Market Cap

$0.82B

Volume

8.99M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

7

Hold

6

Sell

2

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
1 Jun 2026WedbushNeutralNeutralmaintain
13 Apr 2026HC Wainwright & Co.BuySelldowngrade
13 Apr 2026JefferiesBuyHolddowngrade
13 Apr 2026
Leerink Partners
Outperform
Market Perform
downgrade
13 Apr 2026Cantor FitzgeraldOverweightNeutraldowngrade
13 Apr 2026WedbushOutperformNeutraldowngrade
13 Apr 2026JP MorganNeutralUnderweightdowngrade
5 Feb 2026Piper SandlerOverweightOverweightmaintain
4 Feb 2026WedbushOutperformOutperformmaintain
3 Nov 2025BMO CapitalUnderperformMarket Performupgrade